13D/13G Filings - Mereo BioPharma Group plc (MREO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-07-10
4:30 pm
Purchase
2020-06-30 13G Mereo BioPharma Group plc
MREO
Vivo Capital IX, LLC 30,595,624
9.000%
16,480,873increase
(+116.76%)
Filing
History
2020-07-10
4:02 pm
Purchase
2020-07-01 13G Mereo BioPharma Group plc
MREO
Citadel Advisors LLC 31,132,991
8.900%
31,132,991increase
(New Position)
Filing
History
2020-07-10
10:48 am
Sale
2020-06-30 13G Mereo BioPharma Group plc
MREO
BlackRock Inc.
BLK
0
0.000%
-16,478,248decrease
(Position Closed)
Filing
2020-07-02
06:19 am
Purchase
2020-06-30 13G Mereo BioPharma Group plc
MREO
Aspire Capital Fund LLC 20,680,882
6.110%
20,680,882increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3